BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 27153233)

  • 1. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
    Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
    J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate detection of hepatitis B and C virus and viral inhibition of the response.
    Yi Z; Chen J; Kozlowski M; Yuan Z
    Cell Microbiol; 2015 Sep; 17(9):1295-303. PubMed ID: 26243406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
    Wong MT; Chen SS
    Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune system control of hepatitis C virus infection.
    Stuart JD; Salinas E; Grakoui A
    Curr Opin Virol; 2021 Feb; 46():36-44. PubMed ID: 33137689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
    Yang DR; Zhu HZ
    World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection.
    Irshad M; Gupta P; Irshad K
    Viral Immunol; 2019 Apr; 32(3):112-120. PubMed ID: 30817236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-step regulation of interferon induction by hepatitis C virus.
    Oshiumi H; Funami K; Aly HH; Matsumoto M; Seya T
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):127-38. PubMed ID: 23292079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity and HCV.
    Heim MH
    J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
    Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
    mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune responses in hepatitis C virus infection.
    Li K; Lemon SM
    Semin Immunopathol; 2013 Jan; 35(1):53-72. PubMed ID: 22868377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
    Frericks N; Brown RJP; Reinecke BM; Herrmann M; Brüggemann Y; Todt D; Miskey C; Vondran FWR; Steinmann E; Pietschmann T; Sheldon J
    J Virol; 2024 Mar; 98(3):e0192123. PubMed ID: 38319104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and evasion of antiviral innate immunity by hepatitis C virus.
    Horner SM
    J Mol Biol; 2014 Mar; 426(6):1198-209. PubMed ID: 24184198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-virus interactions in hepatitis B and hepatitis C infection.
    Yoshio S; Kanto T
    J Gastroenterol; 2016 May; 51(5):409-20. PubMed ID: 26894594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.
    Kanto T; Hayashi N
    Intern Med; 2006; 45(4):183-91. PubMed ID: 16543687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.